The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma. (Record no. 28956633)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01537 a2200445 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518003419.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201908s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1543-8392 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1021/acs.molpharmaceut.8b00880 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gu, Jie |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190828 |
| 245 00 - TITLE STATEMENT | |
| Title | The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Molecular pharmaceutics |
| Date of publication, distribution, etc. | 11 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 5387-5396 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Acetanilides |
| General subdivision | pharmacokinetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Synergism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heterocyclic Compounds, 3-Ring |
| General subdivision | pharmacokinetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Multiple Myeloma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proteins |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Song, Sha |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Han, Huiying |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xu, Hongxia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fan, Gao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Qian, Chen'ao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Qiu, Yingchun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhou, Wenqi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhuang, Wenzhuo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Bingzong |
| 773 0# - HOST ITEM ENTRY | |
| Title | Molecular pharmaceutics |
| Related parts | vol. 15 |
| -- | no. 11 |
| -- | p. 5387-5396 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00880">https://doi.org/10.1021/acs.molpharmaceut.8b00880</a> |
| Public note | Available from publisher's website |
No items available.